SurModics (SRDX)

Add SRDX Price Alert Hide Sticky Hide Intro

Moderator: No Moderator

Search This Board:

Last Post: 8/2/2012 9:30:11 AM - Followers: 14 - Board type: Free - Posts Today: 0

SRDX Webpage http://www.surmodics.com/index.html & http://www.surmodicspharma.com/index.html

SRDX Conference Call Webcasts: http://phx.corporate-ir.net/phoenix.zhtml?c=80353&p=irol-Audioarchives
SRDX Presentation Slidesets: http://phx.corporate-ir.net/phoenix.zhtml?c=80353&p=irol-presentations
SRDX News Releases: http://phx.corporate-ir.net/phoenix.zhtml?c=80353&p=irol-news&nyo=0

SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?company=&CIK=srdx&filenum=&State=&SIC=&owner=include&action=getcompany

SRDX Short Interest: http://www.nasdaq.com/aspxcontent/shortinterests.aspx?symbol=SRDX&selected=SRDX

Other Useful Websites:

http://www.clinicaltrials.gov/ct2/results?term=surmodics
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/TextResults.cfm
http://www.freepatentsonline.com/result.html?query_txt=surmodics&sort=relevance&srch=top&search=
http://www.techagreements.com/AgreementSearch.aspx?search=normal&query=surmodics

SRDX
Current Price
Volume:

Bid	Ask	Day's Range


SRDX Detailed Quote		Wiki

SRDX News: SurModics Reports Second Quarter Fiscal 2013 Results	05/07/2013 04:00:00 PM
SRDX News: SurModics to Webcast Second Quarter 2013 Earnings Conference Call on May 7	04/30/2013 08:00:00 AM
SRDX News: SurModics' New Low Friction, Low Particulate Device Coatings Introduced	02/11/2013 08:00:00 AM
SRDX News: SurModics to Webcast Annual Meeting on February 11	02/06/2013 07:00:00 AM
SRDX News: SurModics Reports First Quarter Fiscal 2013 Results	01/30/2013 04:01:00 PM

Post	Subject
#2433	The share price has had a nice bump	DewDiligence	08/02/12 09:30:11 AM
#2432	I continue to be impressed with Gary M.	skiplarson98	08/02/12 12:41:59 AM
#2431	~ $SRDX ~ Earnings posted, pending or coming	Fa$tlane	02/06/12 01:49:58 AM
#2430	Bizarre: #msg-71663295	DewDiligence	02/02/12 08:17:24 PM
#2429	Phil Ankeny is NO LOSS. Like so	ktytor	09/15/11 08:07:24 PM
#2428	Re: Ankeny loss...	Democritus_of_Abdera	08/23/11 09:02:49 PM
#2427	Ankeny was the last holdover from the old	DewDiligence	08/23/11 06:08:36 PM
#2426	4:54PM SurModics announces strategic realignment of business; a	surf1944	08/23/11 05:31:18 PM
#2425	Re Q3 Earnings Report...	Democritus_of_Abdera	08/08/11 05:38:15 AM
#2424	Good earnings report but the main thing I	skiplarson98	08/03/11 04:30:20 PM
#2423	JNJ drops Cypher and Nevo: #msg-64256077.	DewDiligence	06/15/11 09:52:04 AM
#2422	PFE restricts PSDV collaboration to a Xalatan implant: #msg-64247589.	DewDiligence	06/14/11 10:51:17 PM
#2421	Thanks, Aslan. I posted the full text of	DewDiligence	05/26/11 04:49:41 PM
#2420	Re: FWIW (ART bioresorbable DES)	aslan2772	05/26/11 03:45:49 PM
#2419	FWIW:	DewDiligence	05/17/11 02:12:58 PM
#2418	FP, thanks for your reply. The Johns Hopkins/Medicare	DewDiligence	05/16/11 06:04:06 AM
#2417	I don't follow Lucentis / Avastin so my	foolishpremise	05/05/11 01:43:39 PM
#2416	Roger that—I wasn't sure if there had been	DewDiligence	04/28/11 05:50:03 PM
#2415	Re: Long-acting Lucentis Formulation - probably not...	Democritus_of_Abdera	04/28/11 05:42:57 PM
#2414	Is SRDX still working on a long-acting formulation	DewDiligence	04/28/11 05:37:15 PM
#2413	Re: Surprising Response to Yesterday’s Q2 CC/Earnings...	Democritus_of_Abdera	04/28/11 05:29:48 PM
#2412	Wow, I listened to the conference call and	skiplarson98	04/28/11 12:23:58 PM
#2411	Simply stated by Aslan, Gary was a breath	skiplarson98	04/28/11 12:09:57 PM
#2410	Plavix PCI Study Shows 6-Months Non-Inferior to 12:	DewDiligence	04/06/11 04:19:49 PM
#2409	SRDX’s Q1 2011 CC...	Democritus_of_Abdera	01/31/11 05:27:42 AM
#2408	re: accounting	aslan2772	01/27/11 01:54:55 AM
#2407	SRDX is resorting to more and more non-GAAP	DewDiligence	01/26/11 07:47:01 PM
#2406	First bioabsorbable stent approved in Europe	bridgeofsighs	01/10/11 01:38:11 PM
#2405	I had not planned on going this year,	skiplarson98	01/07/11 02:38:52 AM
#2404	Ouch...nice catch.	foolishpremise	01/06/11 05:01:28 PM
#2403	Re Annual Mtg on Feb 7...	Democritus_of_Abdera	01/06/11 05:34:47 AM
#2402	Re: Sale of Pharmaceutical Division...	Democritus_of_Abdera	12/16/10 12:35:56 PM
#2401	The potential sale of the pharmaceutical business is	foolishpremise	12/16/10 12:12:44 PM
#2400	Possible sale of pharmaceutical business...	Democritus_of_Abdera	12/14/10 08:17:31 PM
#2399	Gary Maharaj...	Democritus_of_Abdera	12/14/10 05:39:09 PM
#2398	So...they are repeatedly trying to take over biotech	foolishpremise	11/26/10 04:49:32 PM
#2397	FP, DoA et al: You guys may want	DewDiligence	11/26/10 04:33:45 PM
#2396	Thank you for doing all that very thorough groundwork.	foolishpremise	11/25/10 09:33:42 PM
#2395	Kensey Nash as Ramius precedent ...	Democritus_of_Abdera	11/25/10 12:12:15 PM
#2394	Datascope as Ramius precedent ...	Democritus_of_Abdera	11/22/10 07:58:46 PM
#2393	Anti-takeover Provisions ....	Democritus_of_Abdera	11/18/10 05:00:34 PM
#2392	Ramius’ 13D ...	Democritus_of_Abdera	11/17/10 09:12:12 PM
#2391	Safety concerns for DES appear to be evaporating?	aslan2772	11/16/10 03:46:10 PM
#2390	Last night’s CC was a shock...	Democritus_of_Abdera	11/11/10 05:45:36 AM
#2389	Edge Therapeutics License Agreement	aslan2772	11/06/10 03:28:51 AM
#2388	There will be no significant value in what	skiplarson98	10/18/10 01:20:15 PM
#2387	Reorganization into Business Units....	Democritus_of_Abdera	10/15/10 05:34:24 AM
#2386	SRDX is in the news today vis-à-vis extended-release	DewDiligence	10/14/10 02:17:53 PM
#2385	Based on the MACE primary-endpoint numbers, I’m certain	DewDiligence	09/29/10 09:21:51 PM
#2384	Thats an interesting statement. "Both drug-eluting stents performed	foolishpremise	09/29/10 09:11:11 PM
Post	Subject

SurModics (SRDX)

About

Help

Educational

More